210 related articles for article (PubMed ID: 3351041)
1. Benefits of Gd-DTPA for MR imaging of intracranial abnormalities.
Hesselink JR; Healy ME; Press GA; Brahme FJ
J Comput Assist Tomogr; 1988; 12(2):266-74. PubMed ID: 3351041
[TBL] [Abstract][Full Text] [Related]
2. Paramagnetic enhancement of cerebral lesions with gadolinium-DTPA.
Hesselink JR; Dunn WM; Healy ME; Hajek P; Baker L; Brahme FJ
Acta Radiol Suppl; 1986; 369():558-60. PubMed ID: 2980556
[TBL] [Abstract][Full Text] [Related]
3. Gd-DTPA administered MR imaging of intracranial mass lesions: a comparison with CT and precontrast MR.
Mihara F; Hirakata R; Hasuo K; Yasumori K; Yoshida K; Kuroiwa T; Masuda K; Fukui M
Radiat Med; 1989; 7(5):227-35. PubMed ID: 2629036
[TBL] [Abstract][Full Text] [Related]
4. MR contrast enhancement of intracranial lesions with Gd-DTPA.
Hesselink JR; Press GA
Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
[TBL] [Abstract][Full Text] [Related]
5. Gd-DTPA-enhanced MR imaging in pediatric patients after brain tumor resection.
Bird CR; Drayer BP; Medina M; Rekate HL; Flom RA; Hodak JA
Radiology; 1988 Oct; 169(1):123-6. PubMed ID: 3420247
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with routine Gd-DTPA administration for MR imaging of the brain.
Schwaighofer BW; Klein MV; Wesbey G; Hesselink JR
J Comput Assist Tomogr; 1990; 14(1):11-7. PubMed ID: 2298973
[TBL] [Abstract][Full Text] [Related]
7. Gd-DTPA-enhanced MR imaging of the brain in patients with meningitis: comparison with CT.
Chang KH; Han MH; Roh JK; Kim IO; Han MC; Kim CW
AJNR Am J Neuroradiol; 1990; 11(1):69-76. PubMed ID: 2105619
[TBL] [Abstract][Full Text] [Related]
8. Gd-DTPA-enhanced MR imaging of the brain in patients with meningitis: comparison with CT.
Chang KH; Han MH; Roh JK; Kim IO; Han MC; Kim CW
AJR Am J Roentgenol; 1990 Apr; 154(4):809-16. PubMed ID: 2107681
[TBL] [Abstract][Full Text] [Related]
9. Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images.
Wessbecher FW; Maravilla KR; Dalley RW
AJNR Am J Neuroradiol; 1991; 12(4):675-9. PubMed ID: 1882743
[TBL] [Abstract][Full Text] [Related]
10. Extracranial lesions of the head and neck: preliminary experience with Gd-DTPA-enhanced MR imaging.
Robinson JD; Crawford SC; Teresi LM; Schiller VL; Lufkin RB; Harnsberger HR; Dietrich RB; Crim JR; Duckwiler GR; Spickler EM
Radiology; 1989 Jul; 172(1):165-70. PubMed ID: 2740499
[TBL] [Abstract][Full Text] [Related]
11. Increased detection of intracranial metastases with intravenous Gd-DTPA.
Healy ME; Hesselink JR; Press GA; Middleton MS
Radiology; 1987 Dec; 165(3):619-24. PubMed ID: 3317496
[TBL] [Abstract][Full Text] [Related]
12. Gd-DTPA in clinical MR of the brain: 1. Intraaxial lesions.
Brant-Zawadzki M; Berry I; Osaki L; Brasch R; Murovic J; Norman D
AJR Am J Roentgenol; 1986 Dec; 147(6):1223-30. PubMed ID: 3490758
[TBL] [Abstract][Full Text] [Related]
13. Gd-DTPA-enhanced cranial MR imaging in children: initial clinical experience and recommendations for its use.
Elster AD; Rieser GD
AJR Am J Roentgenol; 1989 Dec; 153(6):1265-8. PubMed ID: 2816645
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain.
Stack JP; Antoun NM; Jenkins JP; Metcalfe R; Isherwood I
Neuroradiology; 1988; 30(2):145-54. PubMed ID: 3386808
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M
AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
[TBL] [Abstract][Full Text] [Related]
16. Is Gd-DTPA required for routine cranial MR imaging?
Elster AD; Moody DM; Ball MR; Laster DW
Radiology; 1989 Oct; 173(1):231-8. PubMed ID: 2781014
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging with gadolinium contrast agent in small deep (lacunar) cerebral infarcts.
Regli L; Regli F; Maeder P; Bogousslavsky J
Arch Neurol; 1993 Feb; 50(2):175-80. PubMed ID: 8431136
[TBL] [Abstract][Full Text] [Related]
18. [Brain and spinal tumors: magnetic resonance imaging using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)].
Fang YX
Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):305-7, 22. PubMed ID: 2804747
[TBL] [Abstract][Full Text] [Related]
19. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
Russell EJ; Schaible TF; Dillon W; Drayer B; LiPuma J; Mancuso A; Maravilla K; Goldstein HA
AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
[TBL] [Abstract][Full Text] [Related]
20. [Contrast-enhanced MR imaging using double doses of gadolinium-DTPA in evaluating brain and spinal diseases].
Matsumoto S; Hasuo K; Uchino A; Matsuura Y; Gibo M; Fukui M; Masuda K
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 May; 53(5):503-10. PubMed ID: 8327315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
